The document discusses various topics related to wellness during the COVID-19 pandemic. It promotes regenerative agriculture practices that improve soil health and food resilience. It provides information on organizations working on agroforestry and permaculture in Guatemala and East Africa. The document also discusses early treatment protocols for COVID-19 that include vitamins, minerals, and repurposed drugs. It notes the importance of lifestyle factors like nutrition, exercise, stress reduction, and time in nature for wellness.
In this SlideShare, we'll provide an overview of the biggest vaccination campaign in history. Since governments around the world began vaccinating their populations in December 2020, there is a striking gap between higher-income countries with the rest of the world. To date (10th June 2021), more than 2.25 billion doses have been administered, yet low-income countries are still far behind, receiving only 0.3% of doses administered.
In this section of the coronavirus pandemic series, we discuss the need for an effective COVID-19 vaccine to return to full normalcy. The slides would give a brief overview on how our immune systems work, and how a vaccine would train our immune system to recognize and fight the infection. Current vaccine platform technologies will be compared, and upcoming candidates will be highlighted for newer-generation vaccines. We'll also discuss in-depth on factors involving vaccine manufacturing, hesitancy & acceptance, and contingencies. The market capitalization of pharma companies involved in the development of the coronavirus vaccine will also be compared.
These slides highlight the approved & widely used therapeutics for treating COVID-19 patients (end Q1 2021). At the time of writing, there are 5 therapeutics that have been granted Emergency Use Authorization by the US FDA, mostly being antivirals and monoclonal antibodies (mAbs). The use of corticosteroids and cytokine inhibitors are also showing promise in their ability to reduce case fatalities, progression as well as hospitalization time.
In this SlideShare, we'll provide an overview of the biggest vaccination campaign in history. Since governments around the world began vaccinating their populations in December 2020, there is a striking gap between higher-income countries with the rest of the world. To date (10th June 2021), more than 2.25 billion doses have been administered, yet low-income countries are still far behind, receiving only 0.3% of doses administered.
In this section of the coronavirus pandemic series, we discuss the need for an effective COVID-19 vaccine to return to full normalcy. The slides would give a brief overview on how our immune systems work, and how a vaccine would train our immune system to recognize and fight the infection. Current vaccine platform technologies will be compared, and upcoming candidates will be highlighted for newer-generation vaccines. We'll also discuss in-depth on factors involving vaccine manufacturing, hesitancy & acceptance, and contingencies. The market capitalization of pharma companies involved in the development of the coronavirus vaccine will also be compared.
These slides highlight the approved & widely used therapeutics for treating COVID-19 patients (end Q1 2021). At the time of writing, there are 5 therapeutics that have been granted Emergency Use Authorization by the US FDA, mostly being antivirals and monoclonal antibodies (mAbs). The use of corticosteroids and cytokine inhibitors are also showing promise in their ability to reduce case fatalities, progression as well as hospitalization time.
The Case for Delaying Most Second Shots Grows StrongerElton Sherwin
Should America be delaying first doses for half the country to give a second dose to those who have already received one shot? A growing number of scientists, epidemiologists and doctors say no.
Address to Florida Fruit and Vegetable Association 2015 annual meeting in Palm Beach, FL. Discusses the role of biotechnology in the future of the state's ag crops and how our industries and farmers can better communicate the topic to a concerned public.
Florida Food Crop industries and GMO: Talking to a Concerned PublicUniversity of Florida
Presentation for Certified Crop Advisor extension meeting on how to effectively discuss crop biotechnology with concerned clientele. How to empower producers with information to effectively communicate the information.
2015 Florida Farm Bureau Young Farmers and Ranchers symposium discusses how to engage public dialog in the area of transgenic (GMO) technology. Animal and plant biotech are discussed, along with ways to hone the messaging to communicate effectively with a concerned audience.
New Strategies in Communicating Biotechnology Topics to Concerned ConsumersUniversity of Florida
July 29, 2015 seminar at Monsanto Company, discussing what has been learned from teaching concepts in biotechnology to farmers, dietitians and scientists.
Agricultural biotechnology and the economics of food security and climate cha...ExternalEvents
Agricultural biotechnology and the economics of food security and climate change mitigation presentation by "Daniel Sumner, University of California Davis, Davis, United States of America
"
(EN) 2021 COVID-19 Vaccines Social Buzz Insight Report [SM2Networks]디센트릭 DnA팀
This is a report that analyzes the responses and reputations of the COVID-19 vaccines by country.
We conducted in-depth data analysis such as engagement and correlation as well as simple quantitative analysis of social data generated in Korea, China, Japan and 7 countries with a large number of coronavirus confirmed cases.
If you have any questions about this report, please contact the SM2Networks Marketing Intelligence Team.
Web : www.sm2marketing.co.kr
E-mail : marketing@samhwa.com
Blog_1: https://blog.naver.com/synthesio
Blog_2 : https://blog.naver.com/dmktginsight
Tel : 031-478-1570
#COVID19 #coronavirus #corona vaccine #coronavirus vaccine #COVID vaccine #pfizer #astrazeneca #moderna #sinovac #sinopharm #janssen #novavax
Kevin Folta speaks to the American Seed Trade Association, clarifying subjects in plant genetic improvement. What are the differences between traditional breeding, mutagenesis, transgenic crop technology and other mechanisms? What does the future hold? This talk compares and contrasts the current state of the art of plant genetic improvement.
In animal agriculture the internet is a wealth of information-- good and bad. So if the public wants to learn about livestock farming, what is the likelihood that they will find factual information? One of the big problems is that activists and food fear mongers are ever present in social media. Ranchers and producers tend not to be. These knowledgeable professionals need to be in that space, and using appeals to ethics to drive the discussion. This talk was presented to the Oklahoma Pork Congress in 2016.
The COVID-19 vaccine race is progressing rapidly, with a handful of candidates already entering Phase 3 clinical trials in Q3 2020. Deals are being struck between developed nations and the top vaccine developers to secure doses even before FDA approval. Coalitions & alliances are also being set up to ensure vaccine access for lower-income countries.
Scaling up Ethiopia’s ‘Seeds for Needs’ approach of using agricultural biodiv...Bioversity International
Bioversity International scientist Carlo Fadda presents to the World Bank on the results we have had so far working with partners in Ethiopia to tap into the genetic diversity of the country and the knowledge of farmers, to help them adapt better to climate change.
Find out more about Seeds for Needs: www.bioversityinternational.org/research-portfolio/adaptation-to-climate-change/seeds-for-needs/
Evidence-based policy-making: The role of impact assessment studies and thei...ExternalEvents
Evidence-based policy-making: The role of impact assessment studies and their implications for agricultural biotechnologies presentation by David Spielman, International Food Policy Research Institute, Washington D.C., United States of America
The Case for Delaying Most Second Shots Grows StrongerElton Sherwin
Should America be delaying first doses for half the country to give a second dose to those who have already received one shot? A growing number of scientists, epidemiologists and doctors say no.
Address to Florida Fruit and Vegetable Association 2015 annual meeting in Palm Beach, FL. Discusses the role of biotechnology in the future of the state's ag crops and how our industries and farmers can better communicate the topic to a concerned public.
Florida Food Crop industries and GMO: Talking to a Concerned PublicUniversity of Florida
Presentation for Certified Crop Advisor extension meeting on how to effectively discuss crop biotechnology with concerned clientele. How to empower producers with information to effectively communicate the information.
2015 Florida Farm Bureau Young Farmers and Ranchers symposium discusses how to engage public dialog in the area of transgenic (GMO) technology. Animal and plant biotech are discussed, along with ways to hone the messaging to communicate effectively with a concerned audience.
New Strategies in Communicating Biotechnology Topics to Concerned ConsumersUniversity of Florida
July 29, 2015 seminar at Monsanto Company, discussing what has been learned from teaching concepts in biotechnology to farmers, dietitians and scientists.
Agricultural biotechnology and the economics of food security and climate cha...ExternalEvents
Agricultural biotechnology and the economics of food security and climate change mitigation presentation by "Daniel Sumner, University of California Davis, Davis, United States of America
"
(EN) 2021 COVID-19 Vaccines Social Buzz Insight Report [SM2Networks]디센트릭 DnA팀
This is a report that analyzes the responses and reputations of the COVID-19 vaccines by country.
We conducted in-depth data analysis such as engagement and correlation as well as simple quantitative analysis of social data generated in Korea, China, Japan and 7 countries with a large number of coronavirus confirmed cases.
If you have any questions about this report, please contact the SM2Networks Marketing Intelligence Team.
Web : www.sm2marketing.co.kr
E-mail : marketing@samhwa.com
Blog_1: https://blog.naver.com/synthesio
Blog_2 : https://blog.naver.com/dmktginsight
Tel : 031-478-1570
#COVID19 #coronavirus #corona vaccine #coronavirus vaccine #COVID vaccine #pfizer #astrazeneca #moderna #sinovac #sinopharm #janssen #novavax
Kevin Folta speaks to the American Seed Trade Association, clarifying subjects in plant genetic improvement. What are the differences between traditional breeding, mutagenesis, transgenic crop technology and other mechanisms? What does the future hold? This talk compares and contrasts the current state of the art of plant genetic improvement.
In animal agriculture the internet is a wealth of information-- good and bad. So if the public wants to learn about livestock farming, what is the likelihood that they will find factual information? One of the big problems is that activists and food fear mongers are ever present in social media. Ranchers and producers tend not to be. These knowledgeable professionals need to be in that space, and using appeals to ethics to drive the discussion. This talk was presented to the Oklahoma Pork Congress in 2016.
The COVID-19 vaccine race is progressing rapidly, with a handful of candidates already entering Phase 3 clinical trials in Q3 2020. Deals are being struck between developed nations and the top vaccine developers to secure doses even before FDA approval. Coalitions & alliances are also being set up to ensure vaccine access for lower-income countries.
Scaling up Ethiopia’s ‘Seeds for Needs’ approach of using agricultural biodiv...Bioversity International
Bioversity International scientist Carlo Fadda presents to the World Bank on the results we have had so far working with partners in Ethiopia to tap into the genetic diversity of the country and the knowledge of farmers, to help them adapt better to climate change.
Find out more about Seeds for Needs: www.bioversityinternational.org/research-portfolio/adaptation-to-climate-change/seeds-for-needs/
Evidence-based policy-making: The role of impact assessment studies and thei...ExternalEvents
Evidence-based policy-making: The role of impact assessment studies and their implications for agricultural biotechnologies presentation by David Spielman, International Food Policy Research Institute, Washington D.C., United States of America
A discussion of how social media is used to harm scientists' reputations. A discussion of current issues in genetic engineering. Presented as part of a night with Skeptic Society of St. Louis, 6/10/2016
An overview of the hysteria, fear tactics and misinformation on the Disney Land measles outbreak in order to forward the Government and Pharmaceutical agenda to force vaccinate every human on earth for profit through the chronic illness that vaccination creates: Asthma, Allergies, Autoimmune Disease, Cancer and many other chronic illness that creates a life long customer for the pharmaceutical and medical industry
Insights on Americans' perspectives on the COVID-19 vaccines, with effective language to build confidence in vaccination. Based on a poll conducted Dec. 21-22, 2020, by Frank Luntz and the de Beaumont Foundation in partnership with the American Public Health Association, the National Collaborative for Health Equity, and Resolve to Save Lives, an Initiative of Vital Strategies.
The problem is that we have a health industry that is not concerned with food…
…and a food industry that is not concerned with health.
For further information on how to invest please contact:
Andrew Haythorpe
Founder, Managing Director
Mobile: +61407 737 973
Email: a@bettercells.com
Skype: andrewhaythorpe
Presented to the University-Industry Consortium on March 3, 2015. Kevin M. Folta speaks about his experience at the public interface of GMO education and why there is resistance to good technology.
Alternatives to Antibiotic Use in Food Animal ProductionPewEnvironment
Stephen Jay, M.D., professor of Medicine and Public Health and past founding chair, Department of Public Health, Indiana University School of Medicine.
Mandy Hagan - Advancing Technologies to Feed 9 BillionJohn Blue
Advancing Technologies to Feed 9 Billion - Mandy Hagan, Vice President, State Affairs and Grassroots, Grocery Manufacturers Association, from the 2015 Animal Agriculture Alliance Stakeholders Summit, The Journey to Extraordinary, May 6 - 7, 2015, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2015-the-journey-to-extraordinary
Let Thy Food Be Thy Medicine and Thy Medicine be Thy Food: Improving Health B...HxRefactored
Our health is the greatest gift we have and making informed decisions about the food we eat has been proven to prevent illnesses.
Many people in the US are both overfed and undernourished resulting in myriad health issues. It has been estimated that one-third of the children born in the year 2000 will develop diabetes. This is completely preventable. Scores of academic and medical studies have concluded that the single most important factor in human health is nutrition, and our food (and how it’s produced) is something we can change.
Megan explores the landscape of the US food system and inspire participants to connect the dots between what we eat and our collective health.
Let Food Be thy Medicine & Medicine Be thy Food - HxRefactored 2014 - Megan G...Mad*Pow
Our health is the greatest gift we have and making informed decisions about the food we eat has been proven to prevent illnesses.
Many people in the US are both overfed and undernourished resulting in myriad health issues. It has been estimated that one-third of the children born in the year 2000 will develop diabetes. This is completely preventable. Scores of academic and medical studies have concluded that the single most important factor in human health is nutrition, and our food (and how it’s produced) is something we can change.
Mad*Pow's Experience Design Director, Megan Grocki, explores the landscape of the US food system and inspire participants to connect the dots between what we eat and our collective health.
This presentation is a 45 minute talk to a plant biology faculty at North Carolina State University, 4/21/2015. The presentation speaks of the mechanisms that underlie the current biotech traits, what are the new opportunities, and why there is resistance to good technology-- along with how to get past it.
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityJohn Blue
"Antibiotics and Food Safety: Perceptions vs. Reality - Dr. Richard Raymond, Former Undersecretary for Food Safety, U.S. Department of Agriculture, from the 2014 Minnesota Pork Congress, January 14-15, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2014-minnesota-pork-congress"
Awe of Nature: How Culture & History are Shaping our DestinyJohn Roulac
Thinking of the brilliant Bucky Fuller's idea of spaceship earth, what if we are on a spaceship traveling through space (we are)... what if the way we're producing food on the ship is destroying our oxygen supply? What would you do?
How Regenerative Agriculture Can Save Your Bacon! John Roulac
Presented at the GoOrganic! Seminar in Kentucky, this presentation includes slides on hemp production and invaluable information on regenerative agriculture.
From the last 12,000 years to present day, John Roulac reviews the advancements in Agricultural Technologies, and offers up a regenerative solution for now and generations to come.
Building Brand Community & Authenticity John Roulac
We First Brand Leadership Summit – building a social marketing plan for 2015 together.
"Getting your social marketing right is no easy task with technology and consumer behavior changing so quickly. That’s why we put together a very special, annual 2-day training event where experts from the smartest and most successful brands in the world come together to build a Social Branding Blueprint with you."
John Roulac's deck at the 2014 Brand Leadership Summit in Beverly Hills, CA. Helping companies create a social marketing roadmap for 2015.
Organic Sustainable Foods: Solutions for Health Crisis & Climate Change John Roulac
Super people deserve super foods. For Nutiva, it starts with organic, non-GMO farming—done without chemical pesticides or fertilizers. Our pure superfoods provide vital nutrition while accelerating the organic food movement.
Serving as catalysts, innovators and pathfinders, we inform and inspire, offering thoughtful solutions to planetary challenges. As these ideas take root, communities everywhere are strengthened. We’re B Corp and Green Business certified, holding ourselves accountable to sustainable principles by reducing our carbon footprint, becoming a zero waste facility, and donating 1 percent of our sales.
Join us in raising the bar for social and environmental responsibility. Together we can ensure a vibrant future by revolutionizing the way the world eats!
Nutiva. Nourishing People & Planet.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
4. healthy soil = healthy plants, animals, people & planet
Let's Regenerate
Great Plains Regeneration collaborates with farmers and ranchers to
enhance biological biodiversity which supports human and
socio-economic resiliency.
5. Agroforestry Regeneration Communities accelerates the plantings of food
forests in Guatemala and East Africa.
agroforestryrc.org
https://www.linkedin.com/company/agroforestryrc
6. Contour Lines
Livingston, Guatemala ~ Sean Dixon-Sullivan, Founder
https://contourlines.org/
February 2019 September 2021
agroforestryrc.org
https://www.linkedin.com/company/agroforestryrc
7. regeneration
food resilience
permaculture
syntropic forestry agroecology
empowering women
indigenous
wisdom
better future
soil health
dignity
regenerative
ag
agroforestryrc.org
https://www.linkedin.com/company/agroforestryrc
water cycling
carbon capture
19. Agriculture Linked To Frog Sexual Abnormalities
Some individual animals had both testes and ovaries. (Source: University of Florida, July 5, 2008)
20.
21. Agenda
Section I: FLCCC Alliance Introduction & High-Level Summary of Recent Critical Events
Section II: What Is Ivermectin?
Section III: Review of the International Trials Data Demonstrating Efficacy
• Effective Pre-Exposure Preventative
• Effective Post-Exposure Preventative
• Effective Treatment Across All Stages of the Disease
• Effective in “Long-Haul” COVID-19 Syndrome
Section IV: Overview of Select U.S. Hospitals & Other Providers Using Ivermectin & N.I.H Discussion
Section V: Conclusions & Co-Champions Needed
******* Questions & Answers *******
Section VI: Addendum of Deeper Scientific Data
FRONT LINE COVID -19 CRITICAL CARE ALLIANCE · f l ccc.net
PROPHYLAXIS & TREATMENT PROTOCOLS FOR COVID -19
Pierre Kory, MD, MPA
President, Front Line Covid-19
Critical Care Alliance
www.flccc.net
A Review of the Evidence Base
Demonstrating the Efficacy of
Ivermectin in the Prophylaxis
(Prevention) & Treatment of
COVID-19
FRONT LINE COVID -19 CRITICAL CARE ALLIANCE · f l ccc.net
PROPHYLAXIS & TREATMENT PROTOCOLS FOR COVID -19
Pierre Kory, MD, MPA
President, Front Line Covid-19
Critical Care Alliance
www.flccc.net
A Review of the Evidence Base
Demonstrating the Efficacy of
Ivermectin in the Prevention &
Treatment of COVID-19
22. The Evolution of “BIG SCIENCE” pre and post-COVID
• Only Big RCT’s can “prove” the efficacy of any medicine, preferably done in N. America/Europe
• Only Big Pharma or Big PHA/AMC’s are capable of conducting Big RCT’s or decide on funding
• Only Big RCT’s by Pharma/Big AMC’s are accepted by “Big Journals” while others are rejected
• Only medicines in Big RCT’s published in Big Journals are accepted and recommended by Big PHA’s
• Only medicines recommended by Big PHA’s have “sufficient evidence” and “proven efficacy”
• Only “sufficient evidence/proven efficacy” escape censorship in Big Media/Social Media
• Such a system is heavily influenced by entities with financial interests (ignores off patent/repurposed drugs)
23. THE “DISINFORMATION PLAYBOOK”
A "Disinformation Playbook" has been used for decades by corporations to delay government
action on matters that would adversely affect their income and profit.
• 1. The Fake - Conduct counterfeit science and try to pass it off as legitimate research
• 2. The Blitz - Harass scientists who speak out with results or views inconvenient for industry.
• 3. The Diversion - Manufacture uncertainty about science where little or none exists.
• 4. The Screen - Buy credibility through alliances with academia or professional societies.
• 5. The Fix - Manipulate government officials or processes to influence policy inappropriately.
• New? Tactics:
• Enlist Social Media and Corporate Media Companies to outlaw discussion of the science
• Enlist Medical Journals to selectively publish, reject and retract against repurposed drugs
• Enlist Gov’t Agencies to participate in disinformation, scare tactics
24. INFAMOUS EXAMPLES OF DISINFORMATION
CAMPAIGNS
• Tobacco Industry attacking the science on the harms of tobacco (The Fake/Diversion)
• Georgia Pacific publishing “fake science” on the dangers of asbestos (The Fake)
• Merck manipulating the science around the drug Vioxx (The Fake)
• The NFL intimidating and discrediting scientists reporting link with brain injury (The Blitz)
• Glaxo Smith Kline tries to silence Scientist exposing dangers of drug Avandia (The Blitz)
• American Chemistry Council sows uncertainty about formaldehyde risks (The Diversion)
• Purdue Pharma partners with academic centers to hide dangers of opioids (The Screen)
• Pfizer pressures FDA to downplay risk of animal drug causing high arsenic (The Fix)
25. "This disease is highly preventable and highly treatable."
Dr. Pierre Kory, Florida Summit on COVID
26. TRUSTED NEWS INITIATIVE
• The partners currently within the TNI are: AP, AFP; BBC, CBC/Radio-
Canada, European Broadcasting Union (EBU),Facebook, Financial
Times, First Draft, Google/YouTube, The Hindu, Microsoft , Reuters,
Reuters Institute for the Study of Journalism, Twitter, The Washington
Post.
27. “KILLING HYDROXYCHLOROQUINE”
• HCQ and other repurposed drugs threatened Remdesivir and
$48 Billion Vaccine project via EUA
• HCQ – safe, around for decades, used every Sunday across Africa
• * no cardiac toxicity at standard doses
• Known effective in SARS/MERS – many docs discovered HCQ
worked if given early
28. “THE GUNS OF AUGUST”- PHARMAGEDDON BEGINS
• Entirely focused on Ivermectin, a highly effective, repurposed drug
• N.B. Repurposed drugs are the singular enemy of the pharmaceutical
industry, and have been for decades
• Triggered by.. the meteoric rise in U.S ivermectin prescriptions
29. The Pharmacy Blockade Emerges
• Many pharmacists (fearful & heavily influenced by the societies and agencies)
begin to “refuse to fill” valid ivermectin prescriptions, using the 5 lies:
• “Due to corporate policy”
• “Because we are out of stock”
• “Because we cannot order more”
• “Because it is not FDA approved for COVID-19”
• “Because I refuse to put my license on the line”
• In vast majority of cases, they do not have this authority - violates state law
39. Senior NIH expert
pushes back on growing
vaccine mandates
Matthew Memoli favors vaccinations in vulnerable populations
but argues population level vaccination could hinder the
development of a natural, robust immunity gained through
infection.
thehill.com - Nov. 8, 2021
40. Natural Immunity
‘Between mid-May and mid-August 2021, when the Delta variant
reigned supreme, full vaccination reduced the risk of testing
positive to 64-70%. Past infection without vaccination had a similar
effect (65-77%).’ UK National Statistics
41.
42. “US & EU Cop26
delegates/media don’t
mention soil health,
photosynthesis, regeneration,
carbon drawdown,
grasslands or nitric oxide.
They repeat Netzero, cows,
methane & carbon.”
John W. Roulac
Founder of Nutiva & Executive Producer of Kiss the Ground